Erowid Selegiline (Deprenyl) Vault : Journal Articles

Deprenyl Bibliography
by Erowid.org

DEPRENYL
Deprenyl Prevents Protein Oxidation: Rodriguez-Gomez JA; Venero JL; Vizuete ML; Cano J; Brain Res Mol Brain Res, Vol 46 (No. 1-2) June 1997, 31-38
Deprenyl And 'Excess Mortality': Riggs JE; Clin Neuropharmacol, Vol 20 (No. 3) June 1997, 276-278
Monoamine oxidase B inhibitors. Current status and future potential: CNS Drugs (New Zealand), Vol 6 (No. 3) 1996, 217-236
The neuroprotective and neuronal rescue effects of (-)-deprenyl: Magyar K; Szende B; Lengyel J; Tarczali J; Szatm´ary I; J Neural Transm Suppl, Vol 52():1998;109-23
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa: Parkinson Study Group; Ann Neurol, Vol 39(No 1): Jan 1996; 29-36
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain: Knoll J; Pharmacol Toxicol, Vol 82(No 2):Feb 1998;57-66

Last Modified - Thu, Apr 23, 2009

Created by Erowid 4/3/01

[ Back to Selegiline Vaults ]

[Plants & Drugs] [Mind & Spirit] [Freedom & Law] [Arts & Sciences] [Library] [Search] [About] (content and html © 1995-2009 Erowid.org. Please ask permission before publicly reproducing.)